ConductScience.org, home

Paper18083

Azlocillin: in vitro studies of a new semisynthetic penicillin.

Stewart D and 1 other. Antimicrob Agents Chemother, 1977. Cited by 74 papers, by iCite.

11 sourcespapers-2026-11-12-0.1.0

Download JSON
Cite this record

ConductScience Library. Azlocillin: in vitro studies of a new semisynthetic penicillin. Papers, record 18083. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/18083

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Azlocillin: in vitro studies of a new semisynthetic penicillin.
PubMed
Journal
Antimicrob Agents Chemother
PubMed
Year
1977
PubMed
Publication types
Comparative Study, Journal Article, Research Support, U.S. Gov't, P.H.S.
PubMed
Citations, by iCite
74
iCite
Relative citation ratio, by iCite
4.13
iCite
Revised in PubMed
2021-05-26
PubMed

Authors2

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Stewart DD
2Bodey GPG P

Source PubMed

Topics8

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
BacteriaMajor topic
PenicillinsMajor topic
Enterobacteriaceae
Hydrogen-Ion Concentration
Microbial Sensitivity Tests
Pseudomonas aeruginosa
Staphylococcus aureus
Streptococcus

Source PubMed

References6

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
14,555,556Infections in cancer patients. Results with gentamicin sulfate therapy.Cancer1972https://conductscience.org/library/papers/4555556PubMed
24,580,721Infectious complications in renal transplant recipients.Transplant Proc1973https://conductscience.org/library/papers/4580721PubMed
3836,016Mezlocillin: in vitro studies of a new broad-spectrum penicillin.Antimicrob Agents Chemother1977https://conductscience.org/library/papers/836016PubMed
44,930,281In vitro studies of semisynthetic alpha-(substituted-ureido) penicillins.Appl Microbiol1971https://conductscience.org/library/papers/4930281PubMed
5817,665Pirbenicillin, a new semisynthetic penicillin with broad-spectrum activity.Antimicrob Agents Chemother1976https://conductscience.org/library/papers/817665PubMed
64,591,273Proceedings: Causes of death in cancer patients.Cancer1974https://conductscience.org/library/papers/4591273PubMed

Cited by27

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 74 citations.

PMIDTitleJournalYearIn PapersSource
35,401,470The Chemical Relationship Among Beta-Lactam Antibiotics and Potential Impacts on Reactivity and Decomposition.Front Microbiol2022https://conductscience.org/library/papers/35401470PubMed
7,425,600Pharmacokinetics of azlocillin in subjects with normal and impaired renal function.Antimicrob Agents Chemother1980https://conductscience.org/library/papers/7425600PubMed
7,235,679CI-867, a new semisynthetic penicillin: in vitro studies.Antimicrob Agents Chemother1980https://conductscience.org/library/papers/7235679PubMed
7,152,688[Azlocillin--a new anti-pseudomonas penicillin. A review of the literature and pharmacokinetic studies].Infection1982https://conductscience.org/library/papers/7152688PubMed
7,117,356Elimination of azlocillin in patients with biliary t-tube drainage.Eur J Clin Pharmacol1982https://conductscience.org/library/papers/7117356PubMed
7,002,527Ticarcillin: a review of its pharmacological properties and therapeutic efficacy.Drugs1980https://conductscience.org/library/papers/7002527PubMed
6,919,412Comparative in vitro study of temocillin (BRL 17421), a new penicillin.Antimicrob Agents Chemother1982https://conductscience.org/library/papers/6919412PubMed
6,875,810The pharmacokinetics of furazlocillin in healthy humans.J Pharmacokinet Biopharm1983https://conductscience.org/library/papers/6875810PubMed
6,818,157The in vitro activity of beta-lactam antibiotics against gentamicin and/or carbenicillin-resistant Pseudomonas aeruginosa strains.Infection1982https://conductscience.org/library/papers/6818157PubMed
6,805,423Activities of tobramycin and azlocillin alone and in combination against experimental osteomyelitis caused by Pseudomonas aeruginosa.Antimicrob Agents Chemother1982https://conductscience.org/library/papers/6805423PubMed
6,778,383In vitro evaluation of Ro 13-9904.Antimicrob Agents Chemother1980https://conductscience.org/library/papers/6778383PubMed
6,774,663Comparative bactericidal effects of azlocillin and ticarcillin against Pseudomonas aeruginosa.Antimicrob Agents Chemother1980https://conductscience.org/library/papers/6774663PubMed
6,771,215Selection of variants of Pseudomonas aeruginosa resistant of Beta-lactam antibiotics.Infection1980https://conductscience.org/library/papers/6771215PubMed
6,660,850High-pressure liquid chromatographic quantitation of azlocillin.Antimicrob Agents Chemother1983https://conductscience.org/library/papers/6660850PubMed
6,538,397Comparative efficacies of piperacillin, azlocillin, ticarcillin, aztreonam, and tobramycin against experimental Pseudomonas aeruginosa pneumonia.Antimicrob Agents Chemother1984https://conductscience.org/library/papers/6538397PubMed
6,435,516In vitro activities of ureidopenicillins alone and in combination with amikacin and three cephalosporin antibiotics.Antimicrob Agents Chemother1984https://conductscience.org/library/papers/6435516PubMed
2,751,284Pharmacokinetic comparison of 5 g of azlocillin every 8 h and 4 g every 6 h in healthy volunteers.Antimicrob Agents Chemother1989https://conductscience.org/library/papers/2751284PubMed
525,984Pharmacokinetics of Bay k 4999, a new broad-spectrum penicillin.Antimicrob Agents Chemother1979https://conductscience.org/library/papers/525984PubMed
485,123Comparison of the activities of the new ureidopenicillins piperacillin, mezlocillin, azlocillin, and Bay k 4999 against gram-negative organisms.Antimicrob Agents Chemother1979https://conductscience.org/library/papers/485123PubMed
422,252[Current chemotherapy of infections caused by Pseudomonas aeruginosa (author's transl)].Infection1979https://conductscience.org/library/papers/422252PubMed

See all 27 cited by

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Comments and corrections
  • Genes
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/18083

GET https://conductscience.org/api/papers/v1/18083/cited_by?page=2